This website uses text-to-speech software called Browsealoud to read and / or translate its content . To use Browsealoud, you must allow Browsealoud cookies; the Browsealoud icon will then appear at the bottom right of your screen.
You can find out more about how Browsealoud uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow Browsealoud cookies Do not use Browsealoud
If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).
Please find information on our services and visiting restrictions in our COVID-19 section.
Patients and visitors must wear a face covering in our hospitals.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
Trial categories: Vaccines
Sponsoring organisation: Janssen Vaccines & Prevention B.V
You are invited to take part in a study to investigate a new vaccine against Respiratory Syncytial Virus (RSV), a highly infectious respiratory virus that infects the lungs and breathing passages. The study is being run by the Oxford Vaccine Group at the University of Oxford.
If you are 18 to 50 yrs old and are in good health then you may be eligible to take part in this study. We will provide reimbursement for your time, inconvenience and travel. The total study participation time is 30 weeks.
"What does the study involve?" "What will I have to do?" These are important questions.
For further information, please visit:
http://trials.ovg.ox.ac.uk/trials/prevent-rsv
or contact us on:
Tel: 01865 611400 Email: info@ovg.ox.ac.uk
Back to list of trials